Skip to content

Demonstration Study on the "Hospital-Community-Home" Intelligent Management Model for Chronic Heart Failure

Demonstration Study on the "Hospital-Community-Home" Intelligent Management Model for Chronic Heart Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000215
Enrollment
Unknown
Registered
2026-01-30
Start date
2026-02-20
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Intelligent Management Group:Integration of Traditional Chinese and Western Medicine Intelligent Management
Routine Management Group:Integration of Traditional Chinese Medicine and Western Medicine Routine Management

Sponsors

First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–79 years, regardless of gender; 2. Meeting the diagnostic criteria for chronic heart failure; 3. Able to understand the study content and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients in a critically ill state due to heart failure; 2. Patients with other life-threatening comorbidities (e.g., severe dysfunction of vital organs such as the liver or kidneys, malignant tumors, acute cerebral infarction, etc.); 3. Patients with malignant arrhythmias or severe bradycardia; 4. Patients requiring special treatments during the study period that may interfere with the clinical management of heart failure; 5. Patients scheduled to undergo coronary revascularization, cardiac resynchronization therapy, mechanical circulatory support, or heart transplantation; 6. Patients with psychiatric disorders and poor compliance; 7. Patients deemed by the investigator to be unable to complete the study; 8. Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
The composite cardiovascular event rate within 1 year (defined as cardiovascular death and Cardiovascular death or hospitalization due to heart failure);

Secondary

MeasureTime frame
Incidence of Other Clinical Endpoint Events Within 1 Year (Including Non-Fatal Myocardial Infarction, Non-Fatal Stroke, Malignant Arrhythmias, Unplanned Revascularization, etc.);N-terminal pro-brain natriuretic peptide;KCCQ Score;New York Heart Association Heart Function Classification;6-minute walk distance;Four Diagnostic Methods (TCM) Score;International Scale of Chronic Disease Care;Awareness of Chronic Diseases;Controllable Risk Factor Modification Rate;Cost-Effectiveness Analysis;

Countries

China

Contacts

Public ContactYingfei Bi

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

yingfei1981@163.com13920648942

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026